Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Data backs AZ’s Wilson disease drug, but with a question mark

Fujifilm acquires AI tech to improve fertility treatment

Sarepta shares yo-yo as FDA places hold on Duchenne trial

New countries stockpile antiviral TPOXX as monkeypox outbreak continues

Biogen and Happify partner on digital support for MS patients

RET inhibitors

lillyhq

News/ News/ Oncology

New era of genomic medicine begins as UK approves Lilly’s Retsevmo

Richard Staines Eli Lilly, Merck & Co, MHRA, Oncology, RET inhibitors, thyroid cancer 0 Comment

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung

X

New era of genomic medicine begins as UK approves Lilly’s Retsevmo

https://pharmaphorum.com/news/uk-authorises-lillys-ret-targeted-retsevmo/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

Biogen and Happify partner on digital support for MS patients
Data backs AZ's Wilson disease drug, but with a question mark
GSK pledges £1bn drive for infectious disease R&D
Fujifilm acquires AI tech to improve fertility treatment
Sarepta shares yo-yo as FDA places hold on Duchenne trial

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com